Hativ® ELectrocardiogram Monitoring on Patients With Suspected Arrhythmia

Recruiting now · Not applicable

Conditions studied: Arrhythmia

In brief

The HELP-A study is a multicenter, randomized, controlled trial. A total of 588 patients were enrolled during the 4-year enrollment period and followed for 1 month. This study aims to compare the diagnostic yield of a continuous ECG patch versus an intermittent handheld ECG in patients with arrhythmia symptoms.

Key facts

Study ID

NCT06250712

Run by

Wonju Severance Christian Hospital

People needed

588

Starts

2024-02-22

Expected to finish

2026-12-31

Last updated by the study team

2026-07-21

Who can join

Age: 19 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients who have arrhythmia symptoms but are not diagnosed on a 12-lead electrocardiogram and require additional tests.
• Patients who can use a smartphone

You may not qualify if…

• Patients who have cardiac implantable electronic devices(CIEDs)
• Patients who can't use handheld ECG
• Patient who had syncope

Where it is running

• Chonnam National University Hospital — Gwangju, Dong-gu Jaebongro 42, South Korea (enrolling)
• Wonju Severance Christian Hospital — Wŏnju, Gangwon-do, South Korea (enrolling)
• Hallym University Dongtan Sacred Heart Hospital — Gyeonggi-do, Hwaseong-si Keunjaebong-gil 7, South Korea (enrolling)
• Korea anam hospital — Seoul, South Korea (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.